Ophthopedia Update: Anti-VEGF treatment for wet AMD declines over 7 years: DENVER — A real-world analysis showed increased rates of undertreatment and attrition with anti-VEGF injections in patients with wet age-related macular degeneration over time, resulting in worse visual outcomes.
According…
dlvr.it
DENVER — A real-world analysis showed increased rates of undertreatment and attrition with anti-VEGF injections in patients with wet age-related macular degeneration over time, resulting in worse visual outcomes.
According to a poster presented at the Association for Research in Vision and Ophthalmology meeting, the study aimed to address the knowledge gaps on the long-term impact of nonpersistence in anti-VEGF treatment on visual outcomes.
“We performed a retrospective analysis of the Vestrum Health database to characterize the impact of a 6-month treatment gap in new wet AMD patients
